Vascular Biogenics Ltd. (VBLT)
Vascular Biogenics Ltd. is a clinical-stage biopharmaceutical company, which engages in the development of next-generation, targeted medicines for difficult-to-treat medical conditions. Its product candidates are built off of its platform technologies: Vascular Targeting System (VTS), a gene-based technology targeting newly formed blood vessels and Monocyte Targeting Technology (MTT), an antibody-based technology able to specifically inhibit monocyte migration for immune-inflammatory applications. The company was founded by Dror Harats and Jacob George on January 27, 2000 and is headquartered in Modi'in, Israel.
Address
320 HATCH DRIVE
FOSTER CITY, CA 94404
Founded
2000
Number of Employees
-
Website
http://www.vblrx.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)